Your browser doesn't support javascript.
loading
State of the Evidence for Use of Psychotropic Medications in School-Age Youth.
Shahidullah, Jeffrey D; Roberts, Holly; Parkhurst, John; Ballard, Rachel; Mautone, Jennifer A; Carlson, John S.
Afiliación
  • Shahidullah JD; Department of Psychiatry & Behavioral Sciences, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
  • Roberts H; Department of Psychology, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Parkhurst J; Pritzker Department of Psychiatry & Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Ballard R; Pritzker Department of Psychiatry & Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Mautone JA; Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19146, USA.
  • Carlson JS; Department of Counseling, Educational Psychology, & Special Education, Michigan State University, East Lansing, MI 48824, USA.
Children (Basel) ; 10(9)2023 Aug 26.
Article en En | MEDLINE | ID: mdl-37761415
Psychotropic medications are commonly prescribed to school-aged youth for the management of mental health concerns. This paper describes the current state of evidence for psychotropic medications in school-aged youth. More specifically, the following sections summarize relevant medication research trials and practice parameters pertaining to psychotropic medication prescribing as well as the specific medications indicated for a range of commonly presenting disorders and symptom clusters in school-aged youth. For each of these disorders and symptom clusters, key findings pertaining to the current state of science and practice are highlighted for the purpose of offering patients, clinicians, researchers, and policymakers with nuanced considerations for the role of psychopharmacology within the context of a larger "whole-child" approach to care that relies on the collaboration of providers and services across systems of care to promote optimal child and family health and wellness. The paper concludes with a discussion about supporting the use of medication treatments in schools, including considerations for ensuring effective family-school-health system collaboration to best meet youth mental health needs.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Children (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Children (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos